WORLD HEALTH ORGANIZATION

The FDA warned nine online pet suppliers, including Chewy, against selling unapproved antimicrobial drugs, contributing to antimicrobial resistance. These drugs, also used in human medicine, are making infections more dangerous. Suppliers have 15 days to comply or face legal action. Antimicrobial resistance is a growing global health threat, with significant human and animal impacts.

The 2020 WHO report highlights cancer's global burden, emphasizing prevention, management, and policy needs. In Ghana, despite a 2011 National Strategy for Cancer Control, challenges persist, with breast and cervical cancers being major concerns. Lifestyle changes and late diagnosis worsen outcomes. Policy advancements are crucial for better prevention, screening, and treatment access.

Leishmaniasis, caused by protozoan parasites transmitted by female phlebotomine sandflies, affects millions globally, with 350 million at risk. It manifests as visceral, cutaneous, or mucocutaneous forms, each with distinct symptoms and impacts. Treatment challenges include drug resistance, toxicity, and the need for new therapies. Vector control and chemotherapy are primary strategies, but socio-economic factors complicate prevention and treatment efforts.

Australia faces high antibiotic consumption and increasing bacterial resistance, risking future medical procedures. Experts urge smarter prescribing to combat this serious health challenge, emphasizing the need for action against unnecessary use to prevent a bleak future of untreatable infections.

The Johns Hopkins Center for Health Security welcomed 30 diverse professionals into its 2022 Emerging Leaders in Biosecurity Initiative, marking the most diverse class in program history. Fellows will engage in workshops and networking to enhance biosecurity leadership and expertise, supported by the Open Philanthropy Project.

80% of the world's population relies on traditional medicine due to accessibility and cost. The WHO and India hosted a summit to share best practices and scientific evidence on traditional medicine, aiming to integrate it into national health systems. Traditional medicine, including acupuncture, shows benefits but requires more research for safety and efficacy. The WHO is developing standards to make traditional medicine safer and more accessible globally.

Sarcomas, including Ewing sarcoma (ES), are aggressive tumors originating from mesenchymal cells. ES, primarily affecting children and young adults, is characterized by the EWS-FLI1 fusion protein, crucial for its development. Diagnosis involves imaging and molecular analysis, with treatment combining chemotherapy, surgery, and radiation. Research focuses on targeted therapies, including EWS-FLI1 inhibition, to improve outcomes.

IPG Health launched a pioneering multidisciplinary offering to enhance diversity in clinical trials, addressing underrepresentation across race, gender, age, and intersectional groups. This initiative leverages IPG Health's expertise in medical strategy, data analytics, and patient engagement to overcome barriers in clinical trial participation, aiming for more inclusive treatment innovations and health equity.

A study in PLOS One found dementia in one spouse reduces divorce likelihood, contrasting with higher divorce rates among those with behavioral issues like aggression. Analyzing data from 37 U.S. Alzheimer’s centers, it highlighted dementia's strain on relationships, emphasizing the need for treating symptoms to improve life quality for patients and their families.